+26.1% · 90d
$24.72
-0.66 (-2.60%)
News
(1)April 2026
Cannot generate headline: SEC filing content is missing
EVMNEvommune, Inc.
I apologize, but it looks like the actual text content of the SEC filing (the PDF data) was not included in your request. The input only provided the metadata tags (`<PDF>...</PDF>`) without the document itself. To maintain the detailed, expert analysis you expect, I need the full content of the AR
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%